|
Main
|
|
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
Netherlands Trial Register |
|
Last refreshed on:
|
28 April 2013 |
|
Main ID: |
NTR281 |
|
Date of registration:
|
09/09/2005 |
|
Primary sponsor: |
|
|
Public title:
|
Effentiveness of Assertive Community Treatment versus Care-as-usual for patients with severe and persistent psychiatric disorders.
|
|
Scientific title:
|
Effentiveness of Assertive Community Treatment versus Care-as-usual for patients with severe and persistent psychiatric disorders. - N/A |
|
Date of first enrolment:
|
1/9/2004 |
|
Target sample size:
|
100 |
|
Recruitment status: |
complete |
|
URL:
|
http://www.trialregister.nl/trialreg/admin/rctview.asp?TC=281 |
|
Study type:
|
intervention |
|
Study design:
|
Randomised: Yes; Masking: None; Control: Active; Group: Parallel; Type: 2 or more arms, randomized
|
|
|
Countries of recruitment
|
|
The Netherlands
| | | | | | | |
|
Contacts
|
|
Name:
|
J.W.
Bloemers |
|
Address:
|
GGZ,
P.O. Box 286, Mr. D.U. Stikkerlaan 1,
9670 AG
Winschoten
The Netherlands |
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
|
|
|
Name:
|
S.
Sytema |
|
Address:
|
University Medical Center Groningen (UMCG), Rob Giel Research Center (RGOc),
P.O. Box 30001, Hanzeplein 1
9700 RB
Groningen
The Netherlands |
|
Telephone:
|
+31 (0)50 3614678 |
|
Email:
|
s.sytema@med.umcg.nl |
|
Affiliation:
|
|
| |
|
Key inclusion & exclusion criteria
|
Inclusion criteria: Mental health patients with a Health of the Nation Scales (HoNOS) total score above 14.
Exclusion criteria: N/A
Age minimum:
Age maximum:
Gender:
|
|
Health Condition(s) or Problem(s) studied
|
Mental illness
|
|
Intervention(s)
|
Assertive Community Treatment (ACT).
In ACT the caseload is a shared responsibility for the whole team;
ACT is further characterized by: a low staff-to-patient ratio (1-10 maximally);
in vivo treatment at home of the patient; the inclusion of a wide range of disciplines in the ACT team, including client participation. Fidelity is measured by 28 items.
|
|
Primary Outcome(s)
|
1. Admissions/admission days;
2. Care consumption;
3. Sustained contact with mental health;
4. Life skills.
|
|
Secondary Outcome(s)
|
1. Psychiatric Symptoms;
2. Quality of Life;
3. Satisfaction with care;
4. Family burden.
|
|
Secondary ID(s)
|
|
ISRCTN11281756
|
|
ZonMW project number: 100-103-016
|
|
Source(s) of Monetary Support
|
|
ZON-MW, The Netherlands Organization for Health Research and Development
|
|